121 related articles for article (PubMed ID: 36269681)
1. Cytokeratin 13 (CK13) expression in cancer: a tissue microarray study on 10,439 tumors.
Lennartz M; Ullmann VS; Gorbokon N; Uhlig R; Rico SD; Kind S; Reiswich V; Viehweger F; Kluth M; Hube-Magg C; Bernreuther C; Büscheck F; Putri D; Clauditz TS; Fraune C; Hinsch A; Jacobsen F; Krech T; Lebock P; Steurer S; Burandt E; Minner S; Marx AH; Simon R; Sauter G; Menz A
APMIS; 2023 Feb; 131(2):77-91. PubMed ID: 36269681
[TBL] [Abstract][Full Text] [Related]
2. Cytokeratin 10 (CK10) expression in cancer: A tissue microarray study on 11,021 tumors.
Uhlig R; Abboud M; Gorbokon N; Lennartz M; Dwertmann Rico S; Kind S; Reiswich V; Viehweger F; Kluth M; Hube-Magg C; Bernreuther C; Büscheck F; Clauditz TS; Fraune C; Hinsch A; Jacobsen F; Krech T; Lebok P; Steurer S; Burandt E; Minner S; Marx A; Simon R; Sauter G; Menz A
Ann Diagn Pathol; 2022 Oct; 60():152029. PubMed ID: 36029589
[TBL] [Abstract][Full Text] [Related]
3. Desmoglein 3 (Dsg3) expression in cancer: A tissue microarray study on 15,869 tumors.
Viehweger F; Azem A; Gorbokon N; Uhlig R; Lennartz M; Dwertmann Rico S; Kind S; Reiswich V; Kluth M; Hube-Magg C; Bernreuther C; Büscheck F; Clauditz TS; Fraune C; Jacobsen F; Krech T; Lebok P; Steurer S; Burandt E; Minner S; Marx AH; Simon R; Sauter G; Menz A; Hinsch A
Pathol Res Pract; 2022 Dec; 240():154200. PubMed ID: 36375372
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic and prognostic impact of cytokeratin 18 expression in human tumors: a tissue microarray study on 11,952 tumors.
Menz A; Weitbrecht T; Gorbokon N; Büscheck F; Luebke AM; Kluth M; Hube-Magg C; Hinsch A; Höflmayer D; Weidemann S; Fraune C; Möller K; Bernreuther C; Lebok P; Clauditz T; Sauter G; Uhlig R; Wilczak W; Steurer S; Minner S; Burandt E; Krech R; Dum D; Krech T; Marx A; Simon R
Mol Med; 2021 Feb; 27(1):16. PubMed ID: 33588765
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of superficial oral squamous cell malignancy based on morphometry and immunoexpression of cytokeratin 13 and cytokeratin 17.
Yamashina M; Sato K; Tonogi M; Tanaka Y; Yamane GY; Katakura A
Acta Cytol; 2014; 58(1):67-75. PubMed ID: 24247036
[TBL] [Abstract][Full Text] [Related]
6. Loss of cytokeratin 13 expression in squamous cell carcinoma of the tongue is a possible sign for local recurrence.
Yanagawa T; Yoshida H; Yamagata K; Onizawa K; Tabuchi K; Koyama Y; Iwasa S; Shimoyamada H; Harada H; Omura K
J Exp Clin Cancer Res; 2007 Jun; 26(2):215-20. PubMed ID: 17725101
[TBL] [Abstract][Full Text] [Related]
7. Pan-keratin Immunostaining in Human Tumors: A Tissue Microarray Study of 15,940 Tumors.
Menz A; Gorbokon N; Viehweger F; Lennartz M; Hube-Magg C; Hornsteiner L; Kluth M; Völkel C; Luebke AM; Fraune C; Uhlig R; Minner S; Dum D; Höflmayer D; Sauter G; Simon R; Burandt E; Clauditz TS; Lebok P; Jacobsen F; Steurer S; Krech T; Marx AH; Bernreuther C
Int J Surg Pathol; 2023 Sep; 31(6):927-938. PubMed ID: 35946088
[TBL] [Abstract][Full Text] [Related]
8. Differential Expression of Cytokeratin 13 in Non-Neoplastic, Dysplastic and Neoplastic Oral Mucosa in a High Risk Pakistani Population.
Farrukh S; Syed S; Pervez S
Asian Pac J Cancer Prev; 2015; 16(13):5489-92. PubMed ID: 26225699
[TBL] [Abstract][Full Text] [Related]
9. High prevalence of p16 staining in malignant tumors.
De Wispelaere N; Rico SD; Bauer M; Luebke AM; Kluth M; Büscheck F; Hube-Magg C; Höflmayer D; Gorbokon N; Weidemann S; Möller K; Fraune C; Bernreuther C; Simon R; Kähler C; Menz A; Hinsch A; Jacobsen F; Lebok P; Clauditz T; Sauter G; Uhlig R; Wilczak W; Steurer S; Burandt E; Krech R; Dum D; Krech T; Marx A; Minner S
PLoS One; 2022; 17(7):e0262877. PubMed ID: 35862385
[TBL] [Abstract][Full Text] [Related]
10. Cytokeratin 7 and cytokeratin 20 expression in cancer: A tissue microarray study on 15,424 cancers.
Dum D; Menz A; Völkel C; De Wispelaere N; Hinsch A; Gorbokon N; Lennartz M; Luebke AM; Hube-Magg C; Kluth M; Fraune C; Möller K; Bernreuther C; Lebok P; Clauditz TS; Jacobsen F; Sauter G; Uhlig R; Wilczak W; Steurer S; Minner S; Marx AH; Simon R; Burandt E; Krech T
Exp Mol Pathol; 2022 Jun; 126():104762. PubMed ID: 35390310
[TBL] [Abstract][Full Text] [Related]
11. In situ adenocarcinoma and squamous carcinoma of uterine cervix. Pathological and immunohistochemical analysis with cytokeratin 13.
Raspollini MR; Fambrini M; Marchionni M; Baroni G; Taddei GL
Eur J Obstet Gynecol Reprod Biol; 2007 Oct; 134(2):249-53. PubMed ID: 16949723
[TBL] [Abstract][Full Text] [Related]
12. Brenner tumors but not transitional cell carcinomas of the ovary show urothelial differentiation: immunohistochemical staining of urothelial markers, including cytokeratins and uroplakins.
Riedel I; Czernobilsky B; Lifschitz-Mercer B; Roth LM; Wu XR; Sun TT; Moll R
Virchows Arch; 2001 Feb; 438(2):181-91. PubMed ID: 11253121
[TBL] [Abstract][Full Text] [Related]
13. Potential utility of uroplakin III, thrombomodulin, high molecular weight cytokeratin, and cytokeratin 20 in noninvasive, invasive, and metastatic urothelial (transitional cell) carcinomas.
Parker DC; Folpe AL; Bell J; Oliva E; Young RH; Cohen C; Amin MB
Am J Surg Pathol; 2003 Jan; 27(1):1-10. PubMed ID: 12502922
[TBL] [Abstract][Full Text] [Related]
14. Reduced expression of cytokeratin 4 and 13 is a valuable marker for histologic grading of esophageal squamous intraepithelial neoplasia.
Takashima M; Kawachi H; Yamaguchi T; Nakajima Y; Kitagaki K; Sekine M; Iida T; Takemura K; Kawano T; Eishi Y
J Med Dent Sci; 2012 Mar; 59(1):17-28. PubMed ID: 23896961
[TBL] [Abstract][Full Text] [Related]
15. Large-scale human tissue analysis identifies Uroplakin 1a as a putative diagnostic marker for urothelial cancer.
Reiswich V; Könemann S; Lennartz M; Höflmayer D; Menz A; Chirico V; Hube-Magg C; Fraune C; Bernreuther C; Simon R; Clauditz TS; Sauter G; Hinsch A; Kind S; Jacobsen F; Steurer S; Minner S; Büscheck F; Burandt E; Marx AH; Lebok P; Krech T
Pathol Res Pract; 2022 Sep; 237():154028. PubMed ID: 35872365
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of specific marker CK13 and CK10/13 combined with APM staining for the diagnosis of amniotic fluid embolism and aspiration.
Wang J; Lai Q; Pan H; Sun D; Yu C; Zhang W; Chen J; Ma L; Li L; Zhou R
Forensic Sci Int; 2014 May; 238():108-12. PubMed ID: 24705378
[TBL] [Abstract][Full Text] [Related]
17. [Expression and significance of cytokeratin 13 gene in oral squamous cell carcinoma].
Lv XZ; Chen WT; Zhang CP
Shanghai Kou Qiang Yi Xue; 2005 Aug; 14(4):378-81. PubMed ID: 16155702
[TBL] [Abstract][Full Text] [Related]
18. Combined loss of expression of involucrin and cytokeratin 13 is associated with poor prognosis in squamous cell carcinoma of mobile tongue.
Pandey S; Søland TM; Bjerkli IH; Sand LP; Petersen FC; Costea DE; Senguven B; Sapkota D
Head Neck; 2021 Nov; 43(11):3374-3385. PubMed ID: 34338386
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic and prognostic impact of cytokeratin 19 expression analysis in human tumors: a tissue microarray study of 13,172 tumors.
Menz A; Bauer R; Kluth M; Marie von Bargen C; Gorbokon N; Viehweger F; Lennartz M; Völkl C; Fraune C; Uhlig R; Hube-Magg C; De Wispelaere N; Minner S; Sauter G; Kind S; Simon R; Burandt E; Clauditz T; Lebok P; Jacobsen F; Steurer S; Wilczak W; Krech T; Marx AH; Bernreuther C
Hum Pathol; 2021 Sep; 115():19-36. PubMed ID: 34102222
[TBL] [Abstract][Full Text] [Related]
20. GATA3 Expression in Human Tumors: A Tissue Microarray Study on 16,557 Tumors.
Reiswich V; Schmidt CE; Lennartz M; Höflmayer D; Hube-Magg C; Weidemann S; Fraune C; Büscheck F; Möller K; Bernreuther C; Simon R; Clauditz TS; Blessin NC; Bady E; Sauter G; Uhlig R; Steurer S; Minner S; Burandt E; Dum D; Marx AH; Krech T; Lebok P; Hinsch A; Jacobsen F
Pathobiology; 2023; 90(4):219-232. PubMed ID: 36649695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]